|
ZNF714 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.904200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.146650E-01 |
| Normal-vs-Stage2 |
6.019200E-01 |
| Normal-vs-Stage3 |
5.516400E-03 |
| Normal-vs-Stage4 |
6.148200E-01 |
| Stage1-vs-Stage2 |
6.026000E-01 |
| Stage1-vs-Stage3 |
8.532200E-02 |
| Stage1-vs-Stage4 |
3.958800E-01 |
| Stage2-vs-Stage3 |
1.548770E-01 |
| Stage2-vs-Stage4 |
5.072200E-01 |
| Stage3-vs-Stage4 |
2.516400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.520400E-01 |
| Normal-vs-AfricanAmerican |
6.334400E-01 |
| Normal-vs-Asian |
1.474350E-01 |
| Caucasian-vs-AfricanAmerican |
1.843570E-01 |
| Caucasian-vs-Asian |
1.853440E-01 |
| AfricanAmerican-vs-Asian |
2.994200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.524000E-02 |
| Normal-vs-Female |
8.998400E-01 |
| Male-vs-Female |
2.804200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.165200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.284400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.233600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.030480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.719000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.702200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.280600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.589590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.607700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.418200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.226200E-01 |
| Normal-vs-Grade 2 |
2.367000E-01 |
| Normal-vs-Grade 3 |
6.747200E-01 |
| Normal-vs-Grade 4 |
3.128500E-02 |
| Grade 1-vs-Grade 2 |
3.685600E-01 |
| Grade 1-vs-Grade 3 |
5.685000E-01 |
| Grade 1-vs-Grade 4 |
1.412960E-01 |
| Grade 2-vs-Grade 3 |
8.479400E-01 |
| Grade 2-vs-Grade 4 |
1.787600E-01 |
| Grade 3-vs-Grade 4 |
3.931800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.586900E-04 |
| Normal-vs-ccB subtype |
5.737400E-01 |
| ccA subtype-vs-ccB subtype |
3.863100E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.198440E-01 |
| Normal-vs-N1 |
2.544200E-01 |
| N0-vs-N1 |
7.500000E-01 |
|
|
